Unlock instant, AI-driven research and patent intelligence for your innovation.

Levofloxacin sustained-release eye drop and preparation method thereof

A technology of levofloxacin and sustained-release eye drops, which is applied to medical preparations with non-active ingredients, medical preparations containing active ingredients, organic active ingredients, etc., can solve the problem of damage to the corneal sebum layer, increase in product-related substances, and decline in quality etc. to achieve the effects of reducing dryness and irritation, stabilizing pH value and increasing viscosity

Inactive Publication Date: 2020-03-13
NANJING ZHIHE MEDICINE TECH CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, clinically used levofloxacin eye drops without thickeners cannot stay in the eye for a long time, and multiple eye drops are required to maintain an effective therapeutic concentration; The preservatives in the eye drops not only damage the epidermal layer of the cornea, but also lead to the increase of related substances in the product and the decline in quality.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Levofloxacin sustained-release eye drop and preparation method thereof
  • Levofloxacin sustained-release eye drop and preparation method thereof
  • Levofloxacin sustained-release eye drop and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Embodiment 1: a kind of levofloxacin eye drops, its prescription is

[0020]

[0021] The preparation process comprises the following steps:

[0022] (1), first add 60% to 80% of the prescribed amount of water for injection;

[0023] (2), add sodium hyaluronate, sodium chloride, citric acid, sodium citrate of recipe quantity successively, stir until dissolving;

[0024] (3), add levofloxacin again, stir until dissolving;

[0025] (4), add water for injection to the full amount.

[0026] (5) Sterilize, filter, pack and cover.

Embodiment 2

[0027] Embodiment 2: a kind of levofloxacin eye drops, its prescription is

[0028]

[0029] The preparation process comprises the following steps:

[0030] (1), first add 60% to 80% of the prescribed amount of water for injection;

[0031] (2), add sodium hyaluronate, sodium chloride, citric acid, sodium citrate of recipe quantity successively, stir until dissolving;

[0032] (3), add levofloxacin again, stir until dissolving;

[0033] (4), add water for injection to the full amount.

[0034] (5), the rest of the preparation process is aseptic filtration, packaging and capping.

Embodiment 3

[0035] Embodiment 3: a kind of levofloxacin eye drops, its prescription is

[0036]

[0037] The preparation process comprises the following steps:

[0038] (1), first add 60% to 80% of the prescribed amount of water for injection;

[0039] (2), add sodium hyaluronate, potassium chloride, acetic acid, sodium acetate of recipe quantity successively, stir until dissolving;

[0040] (3), add levofloxacin again, stir until dissolving;

[0041] (4), add water for injection to the full amount.

[0042] (5), the rest of the preparation process is aseptic filtration, packaging and capping.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a levofloxacin sustained-release eye drop and a preparation process thereof. The levofloxacin sustained-release eye drop is prepared from the following components: levofloxacin20-25mg, sodium hyaluronate 10-15mg, sodium chloride 10-15mg, citric acid 2.0-2.5 mg, sodium citrate 6.0-6.5 mg, and water for injection 5ml. The preparation process comprises the following steps: firstly adding 60%-80% of water for injection, sequentially adding sodium hyaluronate, sodium chloride, citric acid and sodium citrate, and stirring until dissolved; adding levofloxacin and stirring until dissolved; adding water for injection to the full amount; sterilizing, filtering, sub-packaging and capping. According to the invention, sodium hyaluronate is added to increase the viscosity of theeye drop, effectively prolong the residence time of the eye drop in the eyes and achieve the slow release effect; the influence of traditional preservatives on product quality, especially related substances is effectively avoided; in the process of stability investigation, the increase of related substances is smaller and the pH value is more stable.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a levofloxacin sustained-release eye drop and a preparation process. Background technique [0002] A variety of bacteria can invade the surface of the human eye, causing eye bacterial infections, the most common being bacterial conjunctivitis and bacterial keratitis. Levofloxacin has a broad antibacterial spectrum, covering most of the Gram-positive bacteria, Gram-negative bacteria and propionibacterium, which are easy to induce ocular infectious diseases and other anaerobic bacteria. Therefore, levofloxacin eye drops can be developed to treat bacterial conjunctivitis and bacterial keratitis caused by sensitive bacteria. [0003] However, clinically used levofloxacin eye drops without thickeners cannot stay in the eye for a long time, and multiple eye drops are required to maintain an effective therapeutic concentration; The preservatives in the eye drops no...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K47/36A61K31/5383A61P27/02A61P31/04A61P31/02
CPCA61K9/0048A61K9/08A61K31/5383A61K47/36A61P27/02A61P31/02A61P31/04
Inventor 张爱琴樊明喜杨谋伟杨君
Owner NANJING ZHIHE MEDICINE TECH CO LTD